There is currently limited information on the prognostic association of molecular aberrations in pleural mesothelioma (PM). We examined the impact of common molecular alterations on overall survival (OS) in a 3-institution cohort from the IASLC 9th edition Staging Project as a pilot study to guide future data collection.
Journal of Thoracic Oncology (JTO) published a clinical update in Oncology on 13 Mar 2026.
The item focuses on The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and PD-L1 Expression on Overall Survival in a Select Cohort from the IASLC 9th Edition Staging Database.
Review the original article for the full source wording and details.